Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Etna Abad"'
Autor:
Etna Abad, Jérémy Sandoz, Gerard Romero, Ivan Zadra, Julia Urgel-Solas, Pablo Borredat, Savvas Kourtis, Laura Ortet, Carlos M. Martínez, Donate Weghorn, Sara Sdelci, Ana Janic
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-25 (2024)
Abstract Background TP53, the most frequently mutated gene in human cancers, orchestrates a complex transcriptional program crucial for cancer prevention. While certain TP53-dependent genes have been extensively studied, others, like the recently ide
Externí odkaz:
https://doaj.org/article/05057dea24dc4caab17c91272a5fc686
Autor:
Amandine Moretton, Savvas Kourtis, Antoni Gañez Zapater, Chiara Calabrò, Maria Lorena Espinar Calvo, Frédéric Fontaine, Evangelia Darai, Etna Abad Cortel, Samuel Block, Laura Pascual‐Reguant, Natalia Pardo‐Lorente, Ritobrata Ghose, Matthew G Vander Heiden, Ana Janic, André C Müller, Joanna I Loizou, Sara Sdelci
Publikováno v:
Molecular Systems Biology, Vol 19, Iss 7, Pp 1-27 (2023)
Abstract While cellular metabolism impacts the DNA damage response, a systematic understanding of the metabolic requirements that are crucial for DNA damage repair has yet to be achieved. Here, we investigate the metabolic enzymes and processes that
Externí odkaz:
https://doaj.org/article/99959834b32e4fb5a1f4c0a860ce238d
Autor:
Julia A. Pavlova, Zimfira Z. Khairullina, Andrey G. Tereshchenkov, Pavel A. Nazarov, Dmitrii A. Lukianov, Inna A. Volynkina, Dmitry A. Skvortsov, Gennady I. Makarov, Etna Abad, Somay Y. Murayama, Susumu Kajiwara, Alena Paleskava, Andrey L. Konevega, Yuri N. Antonenko, Alex Lyakhovich, Ilya A. Osterman, Alexey A. Bogdanov, Natalia V. Sumbatyan
Publikováno v:
Antibiotics, Vol 10, Iss 5, p 489 (2021)
In the current work, in continuation of our recent research, we synthesized and studied new chimeric compounds, including the ribosome-targeting antibiotic chloramphenicol (CHL) and the membrane-penetrating cation triphenylphosphonium (TPP), which ar
Externí odkaz:
https://doaj.org/article/d7e64d55801f418cb67a84cf4c2c37fb
Publikováno v:
The FEBS Journal. 288:2184-2202
A growing body of evidence supports the notion that cancer resistance is driven by a small subset of cancer stem cells (CSC), responsible for tumor initiation, growth, and metastasis. Both CSC and chemoresistant cancer cells may share common qualitie
Autor:
Alena Paleskava, Etna Abad, Ilya A. Osterman, Pavel A. Nazarov, G. I. Makarov, Susumu Kajiwara, Yuri N. Antonenko, Dmitrii A. Lukianov, Zimfira Z Khairullina, Inna A. Volynkina, Julia A. Pavlova, Somay Y Murayama, Alex Lyakhovich, Dmitry A. Skvortsov, Natalia V. Sumbatyan, Andrey G Tereshchenkov, Alexey A. Bogdanov, Andrey L. Konevega
Publikováno v:
Antibiotics, Vol 10, Iss 489, p 489 (2021)
Scientia
Antibiotics
Volume 10
Issue 5
Scientia
Antibiotics
Volume 10
Issue 5
Activitat antibiòtica; Ribosoma bacterià; Simulacions de dinàmica molecular Actividad antibiótica; Ribosoma bacteriano; Simulaciones de dinámica molecular Antibiotic activity; Bacterial ribosome; Molecular dynamics simulations In the current wor
Autor:
Etna Abad, Kate D. Sutherland, Laia Guiu, Sarah A. Best, Ana Janic, Cassandra J. Vandenberg, Margs S. Brennan, Sheryl Ding, Lachlan Whitehead, Andreas Strasser, Marco J Herold
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 10, Pp 1-9 (2020)
Cell Death and Disease, Vol 11, Iss 10, Pp 1-9 (2020)
TP53 is a critical tumor suppressor that is mutated in approximately 50% of human cancers. Unveiling the downstream target genes of TP53 that fulfill its tumor suppressor function is an area of intense investigation. Zmat3 (also known as Wig-1 or PAG
Publikováno v:
Cancer letters. 474
The cancer stem cell (CSC) model defines tumors as hierarchically organized entities, containing a small population of tumorigenic CSC, or tumour-initiating cells, placed at the apex of this hierarchy. These cells may share common qualities with chem
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866:165886